Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
01/2004
01/02/2004EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
01/02/2004EP1373232A1 Method of producing n-substituted 2,6-dialkyl morpholines
01/02/2004EP1373208A1 A process for the synthesis of an aliphatic cyclic amine
01/02/2004EP1373194A1 BENZAMIDE INHIBITORS OF FACTOR Xa
01/02/2004EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals
01/02/2004EP1373188A1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics
01/02/2004EP1372655A2 Cathepsin cysteine protease inhibitors
01/02/2004EP1372615A1 Compounds and compositions for delivering active agents
01/01/2004US20040002606 Reacting a secondary amine with oxidizer; one pot process
01/01/2004US20040002604 Phenylalkynes
01/01/2004US20040002542 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
01/01/2004US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device
01/01/2004US20040002491 Melatonergic receptors
01/01/2004US20040002490 Melatonergic receptors
01/01/2004US20040002481 Novel 4-dedimethylaminotetracycline derivatives
12/2003
12/31/2003WO2004000825A1 Novel compounds
12/31/2003WO2004000824A1 Process for the production of n-(2,6-dimethyl-phenyl)-2-piperazin-1-yl-acetamide
12/31/2003WO2004000823A1 Amorphous form of(-)-}2-}4-}(4-chlorophenyl)-phenyl methyl}-1-piperazinyl] ethoxy] acetic acid dihydrochloride (levocetririzine dihydrochloride)
12/31/2003WO2004000797A1 Alpha-sulfonylamino-acetonitriles
12/31/2003WO2004000789A1 Amide linker peroxisome proliferator activated receptor modulators
12/31/2003WO2004000783A1 Aminoalkylphenols, methods of using and making the same
12/31/2003CN1464881A New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
12/31/2003CN1132825C Process for preparing N-formyl morpholine
12/31/2003CN1132824C Preparation of dodecyl morpholine
12/31/2003CA2489991A1 Amorphous form of(-)-}2-}4-}(4-chlorophenyl)-phenyl methyl}-1-piperazinyl|ethoxy| acetic acid dihydrochloride (levocetririzine dihydrochloride)
12/31/2003CA2488972A1 Amide linker peroxisome proliferator activated receptor modulators
12/30/2003US6670447 Amino acid N-carboxyanhydrides with acyl substituents on nitrogen atoms thereof
12/30/2003US6670376 Aryl aniline β2 adrenergic receptor agonists
12/30/2003US6670358 Substituted thioacetamides
12/30/2003CA2198637C Preparation of quaternized glycine nitriles
12/30/2003CA2051399C Therapeutically useful 2-aminotetralin derivatives
12/29/2003CA2433983A1 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
12/25/2003US20030236438 Enantioselective 1,4-addition of aromatic nucleophiles to alpha,beta-unsaturated aldehydes using chiral organic catalysts
12/25/2003US20030236407 Perfluoroalkyl group-containing micelle-forming triiodoaromatic compounds, process for their production and their use as contrast media
12/25/2003US20030236403 Certain substituted 1-aryl-3-piperazine-1'-yl propanones
12/25/2003US20030236368 Preparation of functionalized alkoxyamine initiator and its use
12/25/2003US20030236269 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
12/25/2003US20030236266 Anticancer agents; viricides; infection therapy
12/25/2003US20030236259 Novel aryl- and heteroarylpiperazines
12/25/2003US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins
12/25/2003US20030236248 Kappa agonist compounds and pharmaceutical formulations thereof
12/25/2003US20030236247 Anticancer agents; autoimmune diseases; antiinflammatory agents
12/25/2003US20030235612 Compounds and compositions for delivering active agents
12/25/2003CA2432964A1 The preparation of functionalized alkoxyamine initiator and its use
12/25/2003CA2432910A1 A process for the synthesis of alkoxyamines and their use in controlled radical polymerization
12/24/2003WO2003106444A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction
12/24/2003WO2003106443A1 1-phenylalkyl-piperazines
12/24/2003WO2003106405A1 Aspartyl protease inhibitors
12/24/2003WO2003106402A1 2-naphtamide derivatives
12/24/2003WO2003106390A1 Polymerisation inhibitor
12/24/2003WO2003084916A3 Compounds that modulate ppar activity and methods for their preparation
12/24/2003WO2003072558A3 Arylsulfone derivatives
12/24/2003WO2003019697A3 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
12/24/2003WO2002028829A3 Peptide deformylase inhibitors
12/24/2003CN1463263A Method to inhibit ethylene responses in plants
12/24/2003CA2489450A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction
12/24/2003CA2489449A1 1-phenylalkyl-piperazines
12/24/2003CA2489286A1 2-naphtamide derivatives
12/24/2003CA2489095A1 Aspartyl protease inhibitors
12/23/2003US6667412 Nitrile compound
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667398 Reacting a benzamidine compound with a amide substituted pyrazole compound
12/23/2003US6667376 Control agents for living-type free radical polymerization and methods of polymerizing
12/23/2003US6667342 Benzenesulfonamide-derivatives and their use as medicaments
12/23/2003US6667309 Such as 3-benzyl-2-cyclopenten-1-one; for treatment of gastrointestinal disorders such as irritable bowel syndrome or esophageal reflux, and inhibiting side effects with administration of erythromycin
12/23/2003CA2208032C Substituted amidinonaphthyl ester derivative
12/18/2003WO2003104213A1 Preparation process of biphenylcarboxylic acid amide derivatives
12/18/2003WO2003104212A1 A novel amorphous form of [2-[4-[(4-chlorophenyl)-phenyl methyl]-1- piperazinyl] ethoxy] acetic acid dihydrochloride (cetirizine dihydrochloride)
12/18/2003WO2003104211A2 Crystalline [2-[4-[(4-chlorophenyl)-phenyl methyl]-1-piperazinyl] ethoxy] acetic acid dihydrochloride
12/18/2003WO2003104167A2 Cyanohydrin ethers and esters as high-sensitivity enzyme substrates
12/18/2003WO2003103665A1 Antiallergic
12/18/2003WO2003103656A1 O-substituted hydroxyaryl derivatives
12/18/2003WO2003103644A2 Guanidino phenylalanin compounds used as urokinase inhibitors
12/18/2003WO2003103602A2 Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
12/18/2003WO2003103567A2 Nitrosodiphenylamine derivatives, compositions comprising them, and the use thereof as antioxidants and spontaneous nitric oxide donors
12/18/2003WO2003074467A3 Urea derivatives as hiv aspartyl protease inhibitors
12/18/2003WO2003072537A3 Selective protein tyrosine phosphatatase inhibitors
12/18/2003US20030232992 Reacting, in the presence of a metal catalyst, a halogenobenzoic acid derivative with benzene derivative to produce biphenyldicarboxylic acid amide derivative
12/18/2003US20030232985 For therapy of Alzheimer's disease and Down's Syndrome
12/18/2003US20030232891 For therapy of pain
12/18/2003US20030232863 Cathepsin cysteine protease inhibitors
12/18/2003US20030232859 Antiinflammatory agents; for treatment of rheumatoid arthritis and multiple sclerosis
12/18/2003US20030232838 6-phenylpyrrolopyrimidinedione derivatives
12/18/2003US20030232836 Secondary amides such as 2-(4-(2- methoxyphenyl)-1-piperazinyl )-N-(3-methylphenyl)acetamide, used for prophylaxis of impotency
12/18/2003US20030232811 Anthranilic acid derivative
12/18/2003US20030232808 Sulfonyl derivatives
12/18/2003US20030232807 Dietetic agents
12/18/2003US20030232806 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them
12/18/2003US20030232804 Glycinamides as factor Xa inhibitors
12/18/2003US20030232801 Identification of compounds for the treatment or prevention of proliferative diseases
12/18/2003US20030232012 For use as in vivo contrast media in nuclear spin tomography (MRT), as blood-pool agents and as lymphographic agents
12/18/2003CA2488367A1 Antiallergic agents
12/18/2003CA2487414A1 Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
12/17/2003EP1371646A1 Aryl-substituted alicyclic compound and medical composition comprising the same
12/17/2003EP1370544A1 Nitric oxide donors based on metallic centres
12/17/2003EP1370528A1 Mch antagonists and their use in the treatment of obesity
12/17/2003EP1370526A1 Diamides which inhibit tryptase and factor xa activity
12/17/2003EP1370525A1 Biguanide derivatives
12/17/2003EP1370520A1 Aryl and biaryl compounds having mch modulatory activity
12/17/2003EP1370514A1 1,3-diamino-4-(aminomethyl)-benzene derivatives and colorants containing said compounds
1 ... 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 ... 341